Syndax Pharmaceuticals (SNDX) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of$1.04. This compares to loss of $0.85 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.77$1.08 per share when it actually produced a loss of $1.10, delivering a surprise of -1.85%.Over the last four quarters, ...